Loading...
•
Jun 30, 2020
Cencora Q3 2020 Earnings Report
AmerisourceBergen's revenue increased slightly, with GAAP EPS at $1.41 and adjusted EPS at $1.85.
Key Takeaways
AmerisourceBergen reported a slight increase in revenue for Q3 2020, with a rise in adjusted diluted EPS. The company raised its adjusted diluted EPS guidance for fiscal year 2020.
Revenue increased 0.3 percent year-over-year to $45.4 billion.
GAAP diluted EPS was $1.41, compared to $1.43 in the prior year quarter.
Adjusted diluted EPS increased 5.1 percent to $1.85.
Adjusted diluted EPS guidance for fiscal 2020 raised to a range of $7.80 to $7.95.
Cencora
Cencora
Forward Guidance
AmerisourceBergen updated its fiscal year 2020 financial guidance to reflect the Company’s continued strong performance and solid execution.
Positive Outlook
- Revenue growth in the mid-single digit percent range, up from the low- to mid- single digit percent range
- Adjusted Diluted EPS to be in the range of $7.80 to $7.95, up from the previous range of $7.35 to $7.65
- Adjusted operating income growth in the mid- to high-single digit percent range, up from the low- to mid-single digit percent range
- Pharmaceutical Distribution Services segment operating income growth in the mid- to high-single digit percent range, up from the low- to mid-single digit percent range
- Other, which is comprised of businesses focused on Global Commercialization Services & Animal Health, operating income growth in the low-single digit percent range, up from operating income decline in the low-single digit percent rage